Selenoproteins in Tumorigenesis and Cancer Progression

被引:82
|
作者
Short, Sarah P. [1 ]
Williams, Christopher S. [1 ,2 ,3 ,4 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN 37235 USA
[2] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[3] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37235 USA
[4] Vet Affairs Tennessee Valley HealthCare Syst, Nashville, TN 37212 USA
来源
关键词
SELENOCYSTEINE TRANSFER-RNA; HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; MAMMALIAN THIOREDOXIN REDUCTASE; APOLIPOPROTEIN-E RECEPTOR-2; PREVENTION TRIAL SELECT; SQUAMOUS-CELL CARCINOMA; RENAL PROXIMAL TUBULE; PROSTATE-CANCER; SELENIUM DEFICIENCY; COLORECTAL-CANCER;
D O I
10.1016/bs.acr.2017.08.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Selenium is a micronutrient essential to human health and has long been associated with cancer prevention. Functionally, these effects are thought to be mediated by a class of selenium-containing proteins known as selenoproteins. Indeed, many selenoproteins have antioxidant activity which can attenuate cancer development by minimizing oxidative insult and resultant DNA damage. However, oxidative stress is increasingly being recognized for its "double-edged sword"effect in tumorigenesis, whereby it can mediate both negative and positive effects on tumor growth depending on the cellular context. In addition to their roles in redox homeostasis, recent work has also implicated selenoproteins in key oncogenic and tumor-suppressive pathways. Together, these data suggest that the overall contribution of selenoproteins to tumorigenesis is complicated and may be affected by a variety of factors. In this review, we discuss what is currently known about selenoproteins in tumorigenesis with a focus on their contextual roles in cancer development, growth, and progression.
引用
收藏
页码:49 / 83
页数:35
相关论文
共 50 条
  • [21] Interleukin-35 is associated with the tumorigenesis and progression of prostate cancer
    Zhu, Jialin
    Yang, Xueling
    Wang, Yan
    Zhang, Haonan
    Guo, Zhi
    ONCOLOGY LETTERS, 2019, 17 (06) : 5094 - 5102
  • [22] TLR inflammation-induced tumorigenesis and progression in colorectal cancer
    Waaga-Gasser, Ana Maria
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 : S107 - S107
  • [23] PYY modulates the tumorigenesis and progression of colorectal cancer unveiled by proteomics
    Jing, Fangyan
    Liu, Guanglong
    Zhang, Renyi
    Xue, Weisong
    Lin, Jiabao
    Zhu, Huacong
    Zhu, Yu
    Wu, Chaosong
    Luo, Yang
    Chen, Tao
    Li, Shenglong
    Bao, Ming
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (12): : 5500 - 5515
  • [24] Cyr61 promotes breast tumorigenesis and cancer progression
    Tsai, MS
    Bogart, DF
    Castañeda, JM
    Li, P
    Lupu, R
    ONCOGENE, 2002, 21 (53) : 8178 - 8185
  • [25] Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
    Jin, Xiao
    Dai, Lu
    Ma, Yilan
    Wang, Jiayan
    Liu, Zheng
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [26] The role of T-box genes in the tumorigenesis and progression of cancer
    Chang, Fangyuan
    Xing, Peipei
    Song, Fengju
    Du, Xiaoling
    Wang, Guowen
    Chen, Kexin
    Yang, Jilong
    ONCOLOGY LETTERS, 2016, 12 (06) : 4305 - 4311
  • [27] Role of p63 in Development, Tumorigenesis and Cancer Progression
    Bergholz, Johann
    Xiao, Zhi-Xiong
    CANCER MICROENVIRONMENT, 2012, 5 (03) : 311 - 322
  • [28] Implications of HIF-1α in the tumorigenesis and progression of pancreatic cancer
    Xiao Jin
    Lu Dai
    Yilan Ma
    Jiayan Wang
    Zheng Liu
    Cancer Cell International, 20
  • [29] PATHOPHYSIOLOGICAL ROLE OF ABERRANT GLYCAN EXPRESSION IN TUMORIGENESIS AND CANCER PROGRESSION
    Barkaszi, Bernadett
    Guttman, Andras
    CHEMICKE LISTY, 2013, 107 : S343 - S345
  • [30] Protocadherin B9 Is Associated with Tumorigenesis and Cancer Progression in Colorectal Cancer
    Asai, Ryuichi
    Taniyama, Daiki
    Oue, Naohide
    Yamamoto, Yuji
    Akabane, Shintaro
    Sentani, Kazuhiro
    Ohdan, Hideki
    Yoshida, Kazuhiro
    Yasui, Wataru
    PATHOBIOLOGY, 2022, 89 (04) : 214 - 221